Skip to main content
. 2021 May 24;9(6):597. doi: 10.3390/biomedicines9060597

Figure 6.

Figure 6

(a) One representative Western blot analysis demonstrating the reduction in growth factors and β-catenin expression in Onco-P20-treated (0.15 μg/mL) NHFs. Proteins were extracted after 2 weeks of treatment. (b) Immuno-enzymatic quantification of IGFBP4, IGFBP6, and VEGF released in the cell culture medium. After 2 weeks of treatment, cells were incubated for an additional 48 h with DMEM without FBS before medium collection. Results were normalized against the protein concentration.